258 related articles for article (PubMed ID: 29181701)
1. Non-alcoholic steatohepatitis induced by induction chemotherapy for pediatric acute lymphoblastic leukemia.
Yamamoto M; Hori T; Igarashi K; Iesato K; Saito M; Miyanishi K; Kikuchi N; Fujita H; Tsutsumi H
Int J Hematol; 2018 Apr; 107(4):390-391. PubMed ID: 29181701
[No Abstract] [Full Text] [Related]
2. Tuberculosis and immune thrombocytopenia.
Madkaikar M; Ghosh K; Jijina F; Gupta M; Rajpurkar M; Mohanty D
Haematologica; 2002 Aug; 87(8):ELT38. PubMed ID: 12161383
[No Abstract] [Full Text] [Related]
3. Drug Rash, Eosinophilia, Systemic Symptoms (DRESS) in a Child With Acute Lymphoblastic Leukemia.
Thakkar D; Singh Y; Yadav SP
J Pediatr Hematol Oncol; 2018 May; 40(4):e266-e267. PubMed ID: 29189510
[No Abstract] [Full Text] [Related]
4. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
Nowak-Göttl U; Ahlke E; Fleischhack G; Schwabe D; Schobess R; Schumann C; Junker R
Blood; 2003 Apr; 101(7):2529-33. PubMed ID: 12517808
[TBL] [Abstract][Full Text] [Related]
5. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
6. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.
Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A;
Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738
[TBL] [Abstract][Full Text] [Related]
7. Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Orgel E; Sposto R; Malvar J; Seibel NL; Ladas E; Gaynon PS; Freyer DR
J Clin Oncol; 2014 May; 32(13):1331-7. PubMed ID: 24687836
[TBL] [Abstract][Full Text] [Related]
8. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
[TBL] [Abstract][Full Text] [Related]
9. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
[TBL] [Abstract][Full Text] [Related]
10. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
11. PTEN abnormalities predict poor outcome in children with T-cell acute lymphoblastic leukemia treated according to ALL IC-BFM protocols.
Szarzyńska-Zawadzka B; Kunz JB; Sędek Ł; Kosmalska M; Zdon K; Biecek P; Bandapalli OR; Kraszewska-Hamilton M; Jaksik R; Drobna M; Kowalczyk JR; Szczepański T; Van Vlierberghe P; Kulozik AE; Witt M; Dawidowska M
Am J Hematol; 2019 Apr; 94(4):E93-E96. PubMed ID: 30614545
[No Abstract] [Full Text] [Related]
12. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
[TBL] [Abstract][Full Text] [Related]
13. Half-and-half nails in a pediatric patient after chemotherapy.
Afsar FS; Ozek G; Vergin C
Cutan Ocul Toxicol; 2015; 34(4):350-1. PubMed ID: 25597374
[TBL] [Abstract][Full Text] [Related]
14. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
[TBL] [Abstract][Full Text] [Related]
15. Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours.
Renard M; Suciu S; Bertrand Y; Uyttebroeck A; Ferster A; van der Werff Ten Bosch J; Mazingue F; Plouvier E; Robert A; Boutard P; Millot F; Munzer M; Mechinaud F; Lescoeur B; Baila L; Vandecruys E; Benoit Y; Philippet P;
Pediatr Blood Cancer; 2011 Jul; 57(1):119-25. PubMed ID: 21412967
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
Parasole R; Petruzziello F; Menna G; Mangione A; Cianciulli E; Buffardi S; Marchese L; Nastro A; Misuraca A; Poggi V
Leuk Lymphoma; 2010 Jun; 51(6):1063-71. PubMed ID: 20470218
[TBL] [Abstract][Full Text] [Related]
17. Testicular function after treatment for acute lymphoblastic leukemia (all) in prepubertal and pubertal boys.
Krawczuk-Rybak M; Solarz E; Wysocka J; Matysiak M; Gadomski A; Kazanowska B; Sega-Pondel D
Pediatr Hematol Oncol; 2009; 26(7):504-14. PubMed ID: 19863206
[TBL] [Abstract][Full Text] [Related]
18. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
[TBL] [Abstract][Full Text] [Related]
19. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.
Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R
Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458
[TBL] [Abstract][Full Text] [Related]
20. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Mejía-Arangure JM; Fajardo-Gutíerrez A; Bernáldez-Ríos R; Rodríguez-Zepeda MC; Espinoza-Hernández L; Martínez-García MC
Arch Med Res; 1997; 28(2):273-9. PubMed ID: 9204621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
